bf/NASDAQ:BDTX_icon.jpeg

NASDAQ:BDTX

Black Diamond Therapeutics

  • Stock

USD

Last Close

3.98

06/11 21:00

Market Cap

288.58M

Beta: 1.88

Volume Today

667.35K

Avg: 83.37K

PE Ratio

−2.55

PFCF: −2.76

OverviewFinancialsAPI

    Description

    Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 dri...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -5-4-3-2-12018-09-302020-02-032021-11-082023-11-062024-11-04

    Revenue (Estimate*)

    0.000.000.010.010.012018-09-302020-02-032021-11-082023-11-062024-11-04

    *Estimate based on analyst consensus